Imaginostics Shines at the Hello Tomorrow Global Summit 2024: Revolutionizing Diagnostic Imaging with QUTE-CE MRI

March 2024 – Valerie Gharagouzloo, co-Founder at Imaginostics, is set to present at the esteemed Hello Tomorrow Global Summit in Paris, France, on March 21st-22nd, showcasing the groundbreaking QUTE-CE MRI technology that is poised to transform diagnostic imaging.

Imaginostics, a finalist in the renowned Hello Tomorrow Global Challenge, was selected from over 4,500 applicants worldwide, a testament to the innovative approach and potential impact of their QUTE-CE MRI technology. The company, under Gharagouzloo’s guidance, specializes in non-invasive, quantitative imaging technology designed to enhance vascular structure and function analysis throughout the body, with significant implications for neurology, cardiology, and oncology.

The Hello Tomorrow Global Summit is an incubator for deep tech advancements, addressing some of the most pressing global challenges through technology and innovation. This year’s summit will not only spotlight the finalists but also serve as a convergence point for industry leaders, investors, and innovators.

“Being recognized as a finalist is a monumental achievement for us,” said Gharagouzloo. “It’s a validation of our hard work and the potential of QUTE-CE MRI to revolutionize how we approach diagnostic imaging for a myriad of diseases. We’re excited to share our technology with the global community and explore partnerships that could further our impact.”

Imaginostics stands at the forefront of the Digital Health & Medical Devices category, promising a future where precise, non-invasive imaging techniques become a cornerstone of personalized medicine. The technology’s precision and its ability to provide 10X better vascular images while eliminating toxic gadolinium contrast underscore its potential to become a game-changer in the field.

The Hello Tomorrow Global Summit offers an unparalleled platform for emerging technologies, highlighting the importance of innovation in tackling health and environmental challenges. For Imaginostics, it represents an opportunity to gain visibility, attract investment, and forge partnerships that could accelerate the adoption of QUTE-CE MRI in healthcare systems worldwide.

As the summit approaches, the Imaginostics team is gearing up for what could be a pivotal moment in the company’s journey. A win at the Hello Tomorrow challenge would not only bring substantial equity-free funding but also access to a tailored coaching program and invaluable connections within the industry.

For more information about Imaginostics and the revolutionary QUTE-CE MRI technology, visit our website or follow us on social media for live updates from the Hello Tomorrow Global Summit.